Cargando…
Lactoferrin for the treatment of COVID-19 (Review)
The coronavirus disease 2019 (COVID-19) outbreak was caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical outcomes of elderly individuals and those with underlying diseases affected by COVID-19 are serious, and may result in acute respiratory distre...
Autores principales: | Wang, Yidan, Wang, Puxiu, Wang, Haoran, Luo, Yifan, Wan, Long, Jiang, Mingyan, Chu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664603/ https://www.ncbi.nlm.nih.gov/pubmed/33199997 http://dx.doi.org/10.3892/etm.2020.9402 |
Ejemplares similares
-
Augmented Renal Clearance: What Have We Known and What Will We Do?
por: Luo, Yifan, et al.
Publicado: (2021) -
LC-MS/MS-Based Serum Metabolomics and Transcriptome Analyses for the Mechanism of Augmented Renal Clearance
por: Wang, Yidan, et al.
Publicado: (2023) -
Lactoferrin for COVID-19 prevention, treatment, and recovery
por: Bolat, Ecem, et al.
Publicado: (2022) -
Myopia Is Suppressed by Digested Lactoferrin or Holo-Lactoferrin Administration
por: Liang, Yifan, et al.
Publicado: (2023) -
Lactoferrin as potential preventative and adjunct treatment for COVID-19
por: Chang, Raymond, et al.
Publicado: (2020)